More on ANIP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $78.37 |
|
|||
| Open | $79.44 | ||||
| 52 Wk High | $70.92 | ||||
| 52 Wk Low | $26.80 | ||||
| Day High | $80.23 | ||||
| Day Low | $78.36 | ||||
| P/E | N/A | ||||
| EPS | $-0.96 | ||||
| Volume | 47,910 | ||||
- Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: BlackRock, Inc.
- ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
- Form 4 ANI PHARMACEUTICALS INC For: Jul 18 Filed by: Cook Meredith
- Form S-8 ANI PHARMACEUTICALS INC
- ANI Pharmaceuticals to appeal Delaware court rulings in CG Oncology case
- ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
- Canaccord Starts ANI Pharmaceuticals (ANIP) at Hold
- Form 4 ANI PHARMACEUTICALS INC For: Jul 13 Filed by: Cook Meredith
- ANI Pharmaceuticals eye implant trial meets both primary endpoints
- ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
Entities mentioned with ANIP
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Raising Prices | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
